395 related articles for article (PubMed ID: 28299631)
1. Clinical characteristics and outcomes of acquired hemophilia A: experience at a single center in Japan.
Ogawa Y; Yanagisawa K; Uchiumi H; Ishizaki T; Mitsui T; Gouda F; Ieko M; Ichinose A; Nojima Y; Handa H
Int J Hematol; 2017 Jul; 106(1):82-89. PubMed ID: 28299631
[TBL] [Abstract][Full Text] [Related]
2. Twelve years of experience of acquired hemophilia A: trials and tribulations in South Australia.
Tay L; Duncan E; Singhal D; Al-Qunfoidi R; Coghlan D; Jaksic W; Szabo F; McRae S; Lloyd J
Semin Thromb Hemost; 2009 Nov; 35(8):769-77. PubMed ID: 20169513
[TBL] [Abstract][Full Text] [Related]
3. Acquired hemophilia A: a review of recent data and new therapeutic options.
Franchini M; Vaglio S; Marano G; Mengoli C; Gentili S; Pupella S; Liumbruno GM
Hematology; 2017 Oct; 22(9):514-520. PubMed ID: 28441921
[TBL] [Abstract][Full Text] [Related]
4. Overshoot of FVIII activity in patients with acquired hemophilia A who achieve complete remission.
Ogawa Y; Yanagisawa K; Naito C; Uchiumi H; Ishizaki T; Shimizu H; Gohda F; Ieko M; Ichinose A; Handa H
Int J Hematol; 2020 Apr; 111(4):544-549. PubMed ID: 31939075
[TBL] [Abstract][Full Text] [Related]
5. A low-dose rituximab regimen for first-line treatment of acquired haemophilia A.
Hunt S; Robertson J; Conn J; Casey J; Royle J; Collins J; Hourigan M; Richmond J; Yang Wang T; Mills A; Mason J
Eur J Haematol; 2022 Jan; 108(1):28-33. PubMed ID: 34528303
[TBL] [Abstract][Full Text] [Related]
6. Inhibitor eradication and bleeding management of acquired hemophilia A: a single center experience in China.
Ye N; Liu Z; Xu G; Wang X; Wu F; Xu X; Wu W
Hematology; 2019 Dec; 24(1):631-636. PubMed ID: 31514689
[No Abstract] [Full Text] [Related]
7. Acquired hemophilia a: retrospective analysis of 49 cases from a single Chinese hemophilia center.
Yang Y; Xue F; Shi H; Wang H; Zhang L; Ji L; Yang R
Clin Appl Thromb Hemost; 2015 Jan; 21(1):35-40. PubMed ID: 23677912
[TBL] [Abstract][Full Text] [Related]
8. A study of 65 patients with acquired hemophilia A in Taiwan.
Huang SY; Tsay W; Lin SY; Hsu SC; Hung MH; Shen MC
J Formos Med Assoc; 2015 Apr; 114(4):321-7. PubMed ID: 25839765
[TBL] [Abstract][Full Text] [Related]
9. Acquired hemophilia.
Bouvry P; Recloux P
Haematologica; 1994; 79(6):550-6. PubMed ID: 7896216
[TBL] [Abstract][Full Text] [Related]
10. Continuous infusion of porcine factor VIII in the management of patients with factor VIII inhibitors.
Rubinger M; Houston DS; Schwetz N; Woloschuk DM; Israels SJ; Johnston JB
Am J Hematol; 1997 Oct; 56(2):112-8. PubMed ID: 9326353
[TBL] [Abstract][Full Text] [Related]
11. Outcome of CARE: a 6-year national registry of acquired haemophilia A in China.
Sun B; Xue F; Feng Y; Sun J; Yu Z; Hou M; Zhang J; Zeng X; Zhao Y; Lian S; Huang M; Niu T; Cui Z; Wu J; Yang R
Br J Haematol; 2019 Dec; 187(5):653-665. PubMed ID: 31372978
[TBL] [Abstract][Full Text] [Related]
12. Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2).
Knoebl P; Marco P; Baudo F; Collins P; Huth-Kühne A; Nemes L; Pellegrini F; Tengborn L; Lévesque H;
J Thromb Haemost; 2012 Apr; 10(4):622-31. PubMed ID: 22321904
[TBL] [Abstract][Full Text] [Related]
13. The tipping point: The critical role of therapeutic apheresis in a case of refractory acquired hemophilia.
Losos M; Scrape S; Joshi S; Shmookler A; Chen J
J Clin Apher; 2017 Dec; 32(6):564-566. PubMed ID: 27646211
[TBL] [Abstract][Full Text] [Related]
14. Inhibitor eradication and treatment for acquired hemophilia A.
Franchini M; Focosi D
Expert Rev Hematol; 2024 Jun; 17(6):233-240. PubMed ID: 38708599
[TBL] [Abstract][Full Text] [Related]
15. Acquired hemophilia in the patient suffering from rheumatoid arthritis: case report.
Drobiecki A; Pasiarski M; Hus I; Sokołowska B; Wątek M
Blood Coagul Fibrinolysis; 2013 Dec; 24(8):874-80. PubMed ID: 24042266
[TBL] [Abstract][Full Text] [Related]
16. Acquired hemophilia: a single-center survey with emphasis on immunotherapy and treatment-related side-effects.
Delgado J; Villar A; Jimenez-Yuste V; Gago J; Quintana M; Hernandez-Navarro F
Eur J Haematol; 2002 Sep; 69(3):158-64. PubMed ID: 12406009
[TBL] [Abstract][Full Text] [Related]
17. Acquired hemophilia A: a frequently overlooked autoimmune hemorrhagic disorder.
Sakurai Y; Takeda T
J Immunol Res; 2014; 2014():320674. PubMed ID: 24741588
[TBL] [Abstract][Full Text] [Related]
18. Treatment of minor severe acquired haemophilia. Is there a rationale for immunoadsorption?
Goldmann G; Marquardt N; Horneff S; Oldenburg J; Zeitler H
Atheroscler Suppl; 2015 May; 18():74-9. PubMed ID: 25936308
[TBL] [Abstract][Full Text] [Related]
19. Identifying risk factors and optimizing standard of care for patients with acquired haemophilia A: Results from a Czech patient cohort.
Salaj P; Geierová V; Ivanová E; Loužil J; Pohlreichová V; Hrachovinová I; Dulíček P
Haemophilia; 2020 Jul; 26(4):643-651. PubMed ID: 32590889
[TBL] [Abstract][Full Text] [Related]
20. [Diagnosis and treatment of congenital and acquired hemophilia].
Higasa S
Rinsho Ketsueki; 2017; 58(7):857-865. PubMed ID: 28781285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
